AGIO
AGIOS PHARMACEUTICALS, INC.
Next earnings Jul 29, 2026 · consensus $-1.71 EPS, $27.6M rev
Last earnings +13.1% on 2026-04-29
$36.20
▼ -0.22%$36.20▲ +1.97%
over 1Y
L $22.34EODHDH $45.49
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.2%
1W+6.0%
1M+27.8%
3M+20.9%
YTD+33.2%
1Y+2.0%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 16 analysts
Buy
Revenue grew 48.0% YoY; but unprofitable (net margin -764.0%).
AGIOS PHARMACEUTICALS, INC. shows $54.0M in FY2025 revenue (+48.0% YoY), a -764.0% net margin, and -34.6% ROE.
Sources: SEC EDGAR (CIK 0001439222, latest 10-Q filed 2026-04-29) · EODHD · as of 6/23/2026, 12:41:36 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.